Principal Investigator
Morgan Freret
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20260290
Clinical Trial Summary
A Phase II Study Assessing the Efficacy of BRain-AVOidant Proton Craniospinal Irradiation (CSI) for Leptomeningeal Metastases (LM) From Solid Tumor Malignancies (BRAVO-LM)
Phase
Phase II
Funding Agency/Sponsor
Institutional
Disease
Neurological Cancer
Contact Information
Phone Number
305-243-2647